Monoclonal Antibody Injection Significantly Reduces COVID-19 Progression
Regeneron Pharmaceuticals, Inc. announced positive data from a Phase 3 trial of recently infected asymptomatic COVID-19 patients, evaluating REGEN-COV ...
Stay updated with breaking news from Viral Load. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regeneron Pharmaceuticals, Inc. announced positive data from a Phase 3 trial of recently infected asymptomatic COVID-19 patients, evaluating REGEN-COV ...
Date Time Historic case linked to Brisbane COVID-19 cluster A historic case with a link to a recent Brisbane cluster has today been added to Queensland’s COVID-19 cases, taking the total to 1,502. Chief Health Officer Dr Jeannette Young said the case, who attended the Byron Bay party, had been in self-isolation and there was no risk to the community. “This case is linked to the second Brisbane cluster that originated from a Princess Alexandra Hospital nurse, taking the total number of cases linked to that cluster to 13,” she said. “As this person had attended the party where COVID-19 ...
A lab scientist scans bar codes on saliva samples collected from members of the CU Boulder community. (Credit: Glenn Asakawa/CU Boulder) A few "super...
email article "Gabapentin is sort of the poster child for limited evidence of benefit." -- Donovan Maust, MD, MS, of the University of Michigan in Ann Arbor, on a study of polypharmacy in patients with dementia. "There's no unseeing and unliving what they lived." -- Kate Judge, executive director of the American Nurses Foundation, on the impact of the pandemic on nurses' mental health. "I was blown away by these results." -- Sharon Hillier, PhD, of the University of Pittsburgh School of Medicine, discussing how a novel drug reduced viral load in treatment-experienced HIV patients ...
Date Time Viruses Mutate, But Treatments Are Static. Is There a Way to Change That? There is a big, global problem: viruses such as HIV and COVID-19 mutate, but treatments for them don’t. For more than 20 years, Leor Weinberger, PhD, has been thinking about how to make vaccines work more efficiently by being adaptive, rather than static. A human T cell (blue) is under attack by HIV (yellow), the virus that causes AIDS. Image by NIH “We’re fighting biology with chemistry,” said Weinberger, director of the Gladstone Center for Cell Circuitry and a professor in the Departments of Pharmac...